Marina Serper, MD, MS

Congratulations to LDI Fellow Marina Serper (@serperm) whose study on strategies for managing cirrhosis pain without drugs has been approved for research funding by the Patient-Centered Outcomes Research Institute (@PCORI).

So incredibly delighted to be joining the @penngihep family for GI fellowship!!! Wouldn’t be here without my amazing family, friends, and mentors. A dream come true to continue to grow and learn from the greats! @PennMedicine

@geneyim @LizzieAbyMD @penngihep @AASLDtweets Thank you so much! Was a whirlwind and I forgot all about social media. (What not to do).

@LizzieAbyMD @penngihep @AASLDtweets Inspiring! @serperm

Absolutely fantastic Starzl lecture by Dr. Marina Serper of @penngihep at #TLM2025!

Award for poster I love hate the most 1. Great epidemiology 2. Too much #cirrhosis in this world #tlm25 @nadimmahmud

Albumin after paracentesis for ascites in cirrhosis is good One of the few remaining indications Congratulate Dr Schechter when you see him #tlm25

A dream come true The LiveSMART trial was able to significantly, substantially reduce falls for patients with cirrhosis and portal hypertension With thanks to Marina Serper, the team, and the patients who inspired us (and co-designed the trial) #tlm25

@OchoaAllemantMD @RosenthalBenjam My mentees are the best part of this academic career! Thank you for the privilege.

The best @SerperM ❤️ @RosenthalBenjam

Inspiring morning hearing @serperm deliver the @AASLDtweets Starzl Transplant Surgery State of the Art lecture, followed by the @penngihep fellow/faculty brunch catching up with some of her mentees

@ebtapper @serperm et al. w/ #TLM25 LB innovative LIVE-SMART program to prevent falls. Therapeutic interventions: lactulose & tele tai-chi (need WiFi) NNT for rx sequence 5 Falls matter and we don’t take enough ownership of the problem. #livertwitter

On the way home, The Tappers listened to Nik Mazumder, Juan Carlos Velez, and THE @serperm on this episode of @COREIMpodcast on hepatorenal syndrome podcasts.apple.com/us/podcast/cor…

@pgholam @AASLDtweets @serperm @SeragHashem I think this would be a great session. If not at TLM then elsewhere In all seriousness, there is a lot of weird stuff that gets done in the name of hepatology.

@GI_Pearls @AASLDtweets @ebtapper @serperm @SeragHashem I meant: -“Correcting” coagulopathy - Albumin for days for undifferentiated AKI - Midodrine in a normotensive HRS-AKI pt - Quinolones in low protein ascites. Never SBP - UDCA for “treatment” of itching or cholestasis And yes…steroids for severe AAH chasing trivial benefit

🏠New concept: Hepatology@Home Delivering expert care to complex patients in the community: Ascitic taps, LVP, antibiotics, diuretics. ✅Feasible ✅Safe ✅Avoids admission It's been v inspiring to watch @TamCarg grow this service from nothing👏 @ebtapper @serperm @NnekaUfereMD

Thank you @AASLDFoundation and #AnnaLok for supporting my transition from fellowship to faculty. This award will be essential in my journey to become a physician-scientist!

Check out new research by LDI Fellow Marina Serper (@serperM) on outcomes across steatotic liver disease subtypes. ⤵️

Incredible innovations will bring more organ transplants to more people and those organs will be able to travel further and function better. Congratulations to Drs Shaver, Bacchetta, Griesemer and Zuckermann. @ttsorg @VUMChealth thelancet.com/journals/lance…

Advances in precision immunosuppression will protect transplant recipients from immunosuppression’s toxicities. When the organ does suffer injury, new deep phenotyping tools will tell us why. Congratulations to Alex Loupy, Marta Sablik and Kiran Khush. thelancet.com/journals/lance…